| mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
0.007 |
0.9 |
| mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.0044 |
0.9 |